All the abovementioned results demonstrated that JPFR inhibited the proliferation and migration of CRC cells partly through regulating the expression of MALAT1 and downstream targets PTBP-2, β-catenin, and MMP7, as well as c-Myc and Cyclin D1. The gene discussed is PTBP2; the disease is colorectal carcinoma.